Provider review
Docberry review
By The Dose Brief Desk · Updated
Docberry’s published Florida weight-loss offer uses multi-month totals; the annual semaglutide equivalent requires a much larger purchase.
Not rated. This review examines published program information; it is not a firsthand treatment review.
At a glance
- Semaglutide
- $796 four months or $2,028 twelve months
- Tirzepatide
- $1,745 three months
- Availability
- The cited service page is Florida-focused; confirm your location.
- Treatment formats
- Prescription semaglutide and tirzepatide weight-loss programs.
Compare full plan totals and obtain cancellation terms before prepaying.
Multi-month totals drive the comparison
Docberry’s prescription weight-loss page lists semaglutide at $796 for four months or $2,028 for twelve. Those are equivalents of $199 and $169 a month, respectively; neither establishes monthly billing. The twelve-month option requires evaluating a much larger total commitment.
Tirzepatide is a separate budget
The same page lists a three-month tirzepatide program at $1,745, about $582 a month when divided by three. Compare that with another three-month offer for the same prescribed formulation and included care, rather than with an introductory first-month advertisement.
Care and location
Docberry describes supplies and follow-up within its program and identifies independent clinical care rather than acting as the pharmacy itself. The service page is Florida-focused. Ask which locations it currently serves and which pharmacy fills the prescribed medication.
Before prepaying for a year
Get written answers about shipment timing, dose changes, stopping for medical reasons and refunds on unused portions. Those questions become more important as the term increases. The reviewed page did not establish all recurring-payment or cancellation conditions, so the published total alone is not enough to judge flexibility.
What stands out
- Full multi-month purchase amounts are available
- Supplies and follow-up are described
What to check
- Annual option increases financial commitment
- Geographic and unused-term rules need confirmation
Sources and review scope
Public information checked in October 2026. Prices and eligibility can change. We have not enrolled in treatment, independently tested medications or verified the licenses of the clinicians and pharmacies involved in an individual prescription. Compounded medications are not FDA-approved; studies of approved brands do not establish that a compounded product has the same safety or effectiveness.